R Squared’s Precigen PGEN Stock Holding History

R Squared’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,470	Closed	-$23.4K	–	667
2025 Q2	$23.4K	Buy	+16,470	New	+$23.4K	0.01%	436

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

R Squared's PGEN Position: Q3 2025 in Review

R Squared sold out of Precigen (PGEN) in Q3 2025, closing a stake of 16,470 shares — an estimated $23.4K sold.

R Squared first reported a position in PGEN in Q2 2025 and held it in 1 quarter. The position peaked at $23.4K in Q2 2025. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.

R Squared reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
R Squared sold 16,470 Precigen shares in Q3 2025, an estimated $23.4K.
R Squared first reported a position in Precigen in Q2 2025 and held it in 1 quarter.
R Squared's Precigen position peaked at $23.4K in Q2 2025.
167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.

Based on R Squared's 13F filing for Q3 2025, filed 12 Nov 2025.